Winners Of 2009 Research Grants Announced By Migraine Research Foundation
September 21st 2009 20:26
Winners Of 2009 Research Grants Announced By Migraine Research Foundation
07 Sep 2009
The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to funding migraine research, has announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain.
The six grants, totaling $300,000, were selected by MRF and its distinguished medical advisory board from an unprecedented 34 proposals from 5 countries. "We were delighted with the depth and breadth of the work represented by these proposals. This is a testament to the enthusiasm and intellect of our researchers today," said Cathy Glaser, co-founder and President of MRF. "To date, we've given $700,000 to some of the most promising investigators to move the science of migraine forward - and we know they're going to make a difference."
Migraine affects more than 30 million Americans - nearly 1 in 4 households - and ranks in the top 20 of the world's most disabling medical illnesses. Yet despite the widespread prevalence and the serious effects on individuals, family and society, research into its causes and treatments is sorely lacking. MRF provides annual research grants to scientists to explore new avenues in migraine and to encourage new researchers to enter the field.
The six MRF grant recipients and their research are:
Yu-Qing Cao, Ph.D, Washington University Pain Center, St. Louis, MO The Effects of Calcium Channel Mutations on Trigeminal Ganglion Neurons Innervating the Dura
Teresa Esposito, Ph.D, Institute of Genetics and Biophysics, Naples, Italy The Role of Ionotropic Glutamate Receptor Genen Migraine
Golda Ginsburg, Ph.D, Johns Hopkins School of Medicine, Baltimore, MD A Pilot Study of Family-Based Cognitive Behavioral Therapy for Treating Chronic Pediatric Headache/Migraine and Comorbid Anxiety
Richard Kraig, MD, Ph.D, University of Chicago Medical Center, Chicago, IL Microglia and Cytokines Modulate Chronic Migraine
Markus Schürks, MD, MSc & Tobias Kurth, MD, ScD, Brigham and Women's Hospital, Boston, MA Identification of Genetic Determinants of the Association Between Migraine and Cardiovascular Events: A Genome-Wide Association Study
Julie Wieseler, Ph.D & Linda Watkins, Ph.D, University of Colorado at Boulder, Boulder, CO Why Opioids Enhance Migraine Pain: The Puzzle Points to Glia
"This year's recipients continue to demonstrate the highly innovative thinking which MRF has encouraged since its founding. The medical community is grateful to the foundation and the investigators it supports," said Dr. Joel Saper, founder of the Michigan Head Pain & Neurological Institute, Ann Arbor, MI, and Chair of MRF's medical advisory board.
The MRF medical advisory board of distinguished scientists, chaired by Dr. Saper, also includes Dr. Rami Burstein (Harvard Medical School, Boston, MA), Dr. F. Michael Cutrer (Mayo Clinic, Rochester, MN), Dr. David W. Dodick (Mayo Clinic, Phoenix, AZ and President-Elect of the American Headache Society), Dr. Peter J. Goadsby (University of California at San Francisco, CA), Dr. Richard Lipton (Albert Einstein College of Medicine, Bronx, NY), Dr. Fred Sheftell (New England Center for Headache, Stamford, CT and President of the American Headache Society), and Dr. Stephen D. Silberstein (Jefferson University Hospital, Philadelphia, PA).
bout the Migraine Research Foundation:
The Migraine Research Foundation is a nonprofit 501(c)(3) organization dedicated to ending the debilitating pain of migraine by funding research into its causes, better treatment options and ultimately, to find a cure.
Source:
Samuel Yates
Migraine Research Foundation
medicalnews.com
Comment by Marjorie Farrington on July 29, 2009 at 4:03pm
Delete Comment Migraine misdiagnosis
Recent studies suggest that up to 90% of "sinus headaches" are migraines.The confusion occurs in part because migraine involves activation of the trigeminal nerves which innervate both the sinus region but also the meninges which surround the brain. As a result, direct determination of the site of pain origination can be confused on a cortical level. Additionally, nasal congestion is not an uncommon result of migraine headaches. A study found that patients with "sinus headache" respond to triptan migraine medications, and state dissatisfaction with their treatment when they are treated with decongestants or antibiotics.
///////////////////////////// ///////////////////////////// ///////////////////////////// ///////////////////////////// ///////////////////////////// //////
Acupuncture may ease chronic headaches
Reuters
NEW YORK (Reuters Health) - Acupuncture may bring some added pain relief to people with chronic headaches, a new study suggests.
The study, the largest to date on using acupuncture to ease headaches, adds to a conflicting body of evidence: Some research has suggested that adding acupuncture to standard headache medication brings patients additional pain relief; other studies, however, have found that "sham" acupuncture -- using blunted needles that do not pierce the skin -- is as effective as the real thing.
Those latter studies call into question the true effectiveness of acupuncture.
Acupuncture may bring some added pain relief to people with chronic headaches, a new study suggests.
For the current study, published in the journal Cephalalgia, German researchers followed more than 15,000 adults with chronic headaches; all had been suffering from either migraine or tension-type headaches at least twice a month for 1 year or more.
Of these patients, nearly 3,200 agreed to be randomly assigned to either have acupuncture added to their regular therapy or to stay with their usual care alone. The rest of the patients began on acupuncture treatment.
All of the acupuncture patients received up to 15 sessions over 3 months, and all study patients were reassessed after 6 months.
In the end, the study found, acupuncture patients reported greater pain improvements than those who stayed with their usual care only. At the outset, they reported an average of 8.4 headache days over 3 months; that dropped to 4.7 by the study's end.
In the usual care only group, the average number of headache days remained virtually the same: 8.1 days initially, and 7.5 days at the end of the study.
http://mymigraines.com/
07 Sep 2009
The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to funding migraine research, has announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain.
The six grants, totaling $300,000, were selected by MRF and its distinguished medical advisory board from an unprecedented 34 proposals from 5 countries. "We were delighted with the depth and breadth of the work represented by these proposals. This is a testament to the enthusiasm and intellect of our researchers today," said Cathy Glaser, co-founder and President of MRF. "To date, we've given $700,000 to some of the most promising investigators to move the science of migraine forward - and we know they're going to make a difference."
Migraine affects more than 30 million Americans - nearly 1 in 4 households - and ranks in the top 20 of the world's most disabling medical illnesses. Yet despite the widespread prevalence and the serious effects on individuals, family and society, research into its causes and treatments is sorely lacking. MRF provides annual research grants to scientists to explore new avenues in migraine and to encourage new researchers to enter the field.
The six MRF grant recipients and their research are:
Yu-Qing Cao, Ph.D, Washington University Pain Center, St. Louis, MO The Effects of Calcium Channel Mutations on Trigeminal Ganglion Neurons Innervating the Dura
Teresa Esposito, Ph.D, Institute of Genetics and Biophysics, Naples, Italy The Role of Ionotropic Glutamate Receptor Genen Migraine
Golda Ginsburg, Ph.D, Johns Hopkins School of Medicine, Baltimore, MD A Pilot Study of Family-Based Cognitive Behavioral Therapy for Treating Chronic Pediatric Headache/Migraine and Comorbid Anxiety
Richard Kraig, MD, Ph.D, University of Chicago Medical Center, Chicago, IL Microglia and Cytokines Modulate Chronic Migraine
Markus Schürks, MD, MSc & Tobias Kurth, MD, ScD, Brigham and Women's Hospital, Boston, MA Identification of Genetic Determinants of the Association Between Migraine and Cardiovascular Events: A Genome-Wide Association Study
Julie Wieseler, Ph.D & Linda Watkins, Ph.D, University of Colorado at Boulder, Boulder, CO Why Opioids Enhance Migraine Pain: The Puzzle Points to Glia
"This year's recipients continue to demonstrate the highly innovative thinking which MRF has encouraged since its founding. The medical community is grateful to the foundation and the investigators it supports," said Dr. Joel Saper, founder of the Michigan Head Pain & Neurological Institute, Ann Arbor, MI, and Chair of MRF's medical advisory board.
The MRF medical advisory board of distinguished scientists, chaired by Dr. Saper, also includes Dr. Rami Burstein (Harvard Medical School, Boston, MA), Dr. F. Michael Cutrer (Mayo Clinic, Rochester, MN), Dr. David W. Dodick (Mayo Clinic, Phoenix, AZ and President-Elect of the American Headache Society), Dr. Peter J. Goadsby (University of California at San Francisco, CA), Dr. Richard Lipton (Albert Einstein College of Medicine, Bronx, NY), Dr. Fred Sheftell (New England Center for Headache, Stamford, CT and President of the American Headache Society), and Dr. Stephen D. Silberstein (Jefferson University Hospital, Philadelphia, PA).
bout the Migraine Research Foundation:
The Migraine Research Foundation is a nonprofit 501(c)(3) organization dedicated to ending the debilitating pain of migraine by funding research into its causes, better treatment options and ultimately, to find a cure.
Source:
Samuel Yates
Migraine Research Foundation
medicalnews.com
Comment by Marjorie Farrington on July 29, 2009 at 4:03pm
Delete Comment Migraine misdiagnosis
Recent studies suggest that up to 90% of "sinus headaches" are migraines.The confusion occurs in part because migraine involves activation of the trigeminal nerves which innervate both the sinus region but also the meninges which surround the brain. As a result, direct determination of the site of pain origination can be confused on a cortical level. Additionally, nasal congestion is not an uncommon result of migraine headaches. A study found that patients with "sinus headache" respond to triptan migraine medications, and state dissatisfaction with their treatment when they are treated with decongestants or antibiotics.
///////////////////////////// ///////////////////////////// ///////////////////////////// ///////////////////////////// ///////////////////////////// //////
Acupuncture may ease chronic headaches
Reuters
NEW YORK (Reuters Health) - Acupuncture may bring some added pain relief to people with chronic headaches, a new study suggests.
The study, the largest to date on using acupuncture to ease headaches, adds to a conflicting body of evidence: Some research has suggested that adding acupuncture to standard headache medication brings patients additional pain relief; other studies, however, have found that "sham" acupuncture -- using blunted needles that do not pierce the skin -- is as effective as the real thing.
Those latter studies call into question the true effectiveness of acupuncture.
Acupuncture may bring some added pain relief to people with chronic headaches, a new study suggests.
For the current study, published in the journal Cephalalgia, German researchers followed more than 15,000 adults with chronic headaches; all had been suffering from either migraine or tension-type headaches at least twice a month for 1 year or more.
Of these patients, nearly 3,200 agreed to be randomly assigned to either have acupuncture added to their regular therapy or to stay with their usual care alone. The rest of the patients began on acupuncture treatment.
All of the acupuncture patients received up to 15 sessions over 3 months, and all study patients were reassessed after 6 months.
In the end, the study found, acupuncture patients reported greater pain improvements than those who stayed with their usual care only. At the outset, they reported an average of 8.4 headache days over 3 months; that dropped to 4.7 by the study's end.
In the usual care only group, the average number of headache days remained virtually the same: 8.1 days initially, and 7.5 days at the end of the study.
http://mymigraines.com/
| 44 |
| Vote |
